Navigation Links
Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
Date:11/21/2008

NEW YORK, Nov. 21 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease released today the following Letter to Shareholders from Dr. Daniel Chain, its Chairman and CEO.

Dear Shareholders,

It is my privilege to serve as Chairman and CEO of Intellect Neurosciences Inc., which I helped found in 2005. As this year draws to a close, I would like to update you regarding the Company's activities and achievements. I am proud to report that Intellect has made important progress in key areas that I believe will add enormously to the future value of the Company and reward you for your support.

Our strategy to bring Intellect to a leading position in the creation of treatments for Alzheimer's disease ("AD") has three components:

  1. Create transforming technology platforms around which we build a valuable patent estate;
  2. Identify and develop product candidates that will be owned by Intellect and licensed to pharmaceutical partners at increasingly advanced stages of development;
  3. Leverage our investment in our technology platform through non-exclusive licenses to pharmaceutical companies that use our technology to develop drugs independently, and collaborations based on our own product candidates with pharmaceutical companies that have the resources required to bring such product candidates to market;

Intellect has made significant progress in each component of the strategy. Some highlights follow:

  1. Create transforming technology and expand the patent estate:

  • We obtained a pivotal patent related to our AN
    '/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
4. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
5. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
6. Amarin Secures Global Intellectual Property Rights for Lipid Programs
7. ActivBiotics Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million
8. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
9. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
10. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
11. IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... (PRWEB) May 20, 2013 Researchers from the ... the connection between lower back pain, and the acne causing ... in the system the bacteria seek out oxygen deprived location ... in the spinal column, P.acnes has the ability to live ... , Fernando Perez, a spokesman for “ The best acne ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 The ... announced the appointment of Lisa Baird as Executive Director. ... July 8, 2013. The WMIS vision is ... applications to understand and effectively treat diseases in the ... Society (WMIS) was established in 2011 by integrating the ...
(Date:5/17/2013)... 17, 2013 Oven Industries Inc. announces ... 5R6-900 temperature controller has many user-friendly benefits. Contained all ... the wall as a self-contained temperature control ... detail makes the device unique, as well as highly ... also be used universally, which allows the user to ...
(Date:5/17/2013)... PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability ,     New ... insect pressures , Syngenta unveiled ... celebration today at the company’s RTP Innovation Center. The ... allows company researchers to simulate any agricultural climate and ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2WMIS Appoints Lisa Baird as Next Executive Director 2New Temperature Control Products Announced by Oven Industries Inc. 2Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... 8 InteKrin Therapeutics, Inc.,will present at the 27th ... Time on Tuesday, January 13, 2009, to be held ... Therapeutics, President and,CEO Denny Lanfear will present at the ... http://www.InteKrin.com ): , InteKrin Therapeutics ...
... 8 AcelRx Pharmaceuticals, Inc.,announced today it has ... In this new position, Dr. Skowronski will ... and providing medical input,and review of clinical development ... the company,s Chief Medical Officer. , ...
... Last 10 Years Helping Implement World Bank HIV/AIDS and ... that Dr. John Osika has joined the company as ... Dr. Osika, a board certified physician in the ... health expert with extensive experience working on HIV/AIDS and ...
Cached Biology Technology:InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13 2Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates 2
(Date:5/17/2013)... antelope can live at elevations of 4,000-5,000m on ... in Nature Communications , investigators from Qinghai ... some genetic factors may be associated with the ... in this work will also provide implications for ... other ruminant species. , The Tibetan antelope ( ...
(Date:5/16/2013)... 2013) Illustrating a commitment to the support ... Association (AGA) Research Foundation has announced the inaugural ... Award recipients. Supported by the National Institute of ... new award helps underrepresented minority students to further ... research. , "By establishing this new award, AGA ...
(Date:5/16/2013)... shown a gene involved in neurodegenerative disease also plays ... circadian clock. , In a study of the ... Ataxin-2, keeps the clock responsible for sleeping and waking ... of the fruit fly,s sleep-wake cycle is disturbed, making ... fly. , The discovery is particularly interesting because ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2Gene involved in neurodegeneration keeps clock running 2
... SNM Symposium on Multimodality Cardiovascular Molecular Imaging ... stem cell therapy, leading-edge research in imaging technology ... imaging of cardiovascular receptors, vascular biology, myocardial metabolism ... International Partnership for Critical Markers of Disease will ...
... to exercise, is a familiar phenomenon, even if the phrase ... barely make it around the block. After jogging regularly for ... two, then three. With regular exercise, the body adapts, becoming ... delivering more oxygen to the muscles. The muscles get stronger, ...
... 2009) -- Guruprasad Madhavan is working on neuromuscular stimulation ... mild cognitive impairment -- all related to low blood ... why he was selected the IEEE/IEEE-USA,s 2009 "New Face ... has multiplied, and so has my responsibility to better ...
Cached Biology News:SNM Symposium on Multimodality Cardiovascular Molecular Imaging 2Symposium to look at genetic basis of exercise 2Symposium to look at genetic basis of exercise 3Biomedical engineering student recognized as IEEE's 'New Face of Engineering' 2
... Myogenesis Kit provides the reagents to ... mature skeletal myotubes. By efficiently promoting ... valuable tool in studies examining myogenesis, ... strategies for muscle cell replacement therapy. ...
... is an automated, confocal, real-time, single cell ... been integrated into a single, compact unit. ... provide high-resolution, automated confocal imaging with sophisticated ... cell-based assays. The system allows the user ...
... uses a simplified procedure and streamlines the ... kit is based on the three step ... sodium bisulfite where cytosine is converted into ... in-column desulphonation reaction eliminates several precipitation steps ...
... Phosphate Assay Kit is based on quantification ... Green, molybdate and free orthophosphate. The rapid ... conveniently measured on a spectrophotometer (600-660 nm) ... colorimetric assay kits have been optimized to ...
Biology Products: